Cargando…
MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1
MicroRNA-641 (miR-641) was significantly decreased in various cancers, but its roles in endometrial cancer (EC) remain unclear. We explored the influences of miR-641 on the EC cells. In our study, the miR-641 expression was reduced in EC cells. Overexpression of miR-641 inhibited viability and proli...
Autores principales: | Dong, Yanfen, Yang, He, Hua, Handan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546697/ https://www.ncbi.nlm.nih.gov/pubmed/36212964 http://dx.doi.org/10.1155/2022/7918596 |
Ejemplares similares
-
Retracted: MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Circular RNA-CDR1as acts as the sponge of microRNA-641 to promote osteoarthritis progression
por: Zhang, Wei, et al.
Publicado: (2020) -
Association of Impulsivity and Polymorphic MicroRNA-641 Target Sites in the SNAP-25 Gene
por: Németh, Nóra, et al.
Publicado: (2013) -
Long non-coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA-641/RAB14 axis
por: Zhao, Guangliang, et al.
Publicado: (2021) -
MicroRNA-103 regulates the progression in endometrial carcinoma through ZO-1
por: Du, Jing, et al.
Publicado: (2019)